Maximus vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Willow beats Maximus overall, scoring 7.5/10 vs 7.1/10. Maximus is more affordable at $150/mo vs $299/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at Maximus and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Maximus

#45 of 52

7.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Higher Rated

Willow

#24 of 52

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Maximus	Willow
Our Score	7.1/10	7.5/10
Starting Price	$150/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Men who want GLP-1 alongside testosterone or other men's health protocols	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#45	#24
Get started	Visit Maximus	Visit Willow

Pros & Cons Compared

Maximus

Pros

+Lowest entry price in the market, $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
+GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
+Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
+Free expedited shipping on all medication orders

Cons

−The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
−Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
−Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Maximus with a score of 7.5/10 vs 7.1/10. If budget is your priority, Maximus starts at $150/mo compared to Willow's $299/mo. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Maximus nor Willow feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review